ACQUIREDStale
Iovance Biotherapeutics Inc · NASDAQ
+15,626 sh
Filed 10 Sept 2026SEC Form 4view source
Iovance Biotherapeutics Inc · NASDAQ
+15,626 sh
Iovance Biotherapeutics Inc · NASDAQ
−6,638 sh · $57.8K
Iovance Biotherapeutics Inc · NASDAQ
+41,669 sh
Iovance Biotherapeutics Inc · NASDAQ
−17,702 sh · $146.6K